{"product_id":"high-risk-localized-and-locally-advanced-prostate-cancer-9783036581682","title":"High-Risk Localized and Locally Advanced Prostate Cancer","description":"\u003cp\u003e • Author(s): Kouji Izumi\u003cbr\u003e • Publisher: Mdpi AG\u003cbr\u003e • Publisher Imprint: Mdpi AG\u003cbr\u003e • BISAC: Pharmacology\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eAround 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of \"high-risk\" may need to be validated first. Although recent advances in radiotherapy for prostate cancer have yielded excellent long-term results, even in high-risk localized disease, there are no studies directly comparing it with local treatment options, such as prostatectomy. To address current challenges in high-risk localized and locally advanced prostate cancer, 12 original and 3 review articles covering aspects from basic research to clinical trials are published in this Special Issue.\u003c\/p\u003e","brand":"Mdpi AG","offers":[{"title":"Hardcover","offer_id":45414569803927,"sku":"9783036581682","price":5813.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0666\/3471\/1191\/files\/9783036581682.webp?v=1768585664","url":"https:\/\/atlanticbooks.com\/products\/high-risk-localized-and-locally-advanced-prostate-cancer-9783036581682","provider":"Atlantic Books","version":"1.0","type":"link"}